PCBP2 and neoplasm: MiR-214 regulates tumor progression by targeting mRNAs encoding proteins such as poly(rC) binding protein-2 (PCBP2), E2F transcription factor 2 (E2F2), and the SUMO-conjugating enzyme UBC9 [12–14].